The Joint Committee of Nurses and Medicines has adopted regulatory amendments that have led to the removal of the requirement for nurses to obtain or obtain a separate standardization authorization (Rx) (#0017). Find out more here. A. There are alternatives depending on when someone was originally authorized. It is defined in Regulations 18 VAC 90 -30-105 for NPs and there are additional standards requirements for NPs, which are located in 18 VAC 90-40-55. You can access it from our website dhp.virginia.gov and then go to the Board of Nursing. Click here to see the applicable care regulation 18 VAC 90-19-200 As of August 2018, 71 PNs in Virginia have received a federal waiver to treat opioid addiction with products containing buprenorphine. In accordance with its standardization power and with appropriate training or experience, an NP may, in independent practice, obtain a federal waiver declaration to distribute products containing buprenorphine. An NP who prescribes while supervised by a physician may be able to obtain a federal waiver with appropriate training or experience, and as long as the supervising physician is certified, trained or licensed to treat and treat patients with an opioid use disorder. Some NPPs who complete 5 years of full-time clinical experience as a registered nurse practitioner under a practice agreement with a physician may practice independently. Will.

Code 54.1-2957.01 (A) It is important that HB 793 does not limit the ability of employers or health systems to require a practice agreement for their nurse practitioners. Regardless of the granting of a self-practice license, an employer may require a nurse to practice in particular environments or in all environments with a practice agreement. A. Contact the Board of Nursing at 804-367-4515 or visit its website in dhp.virginia.gov/ Since August 2018, 15 PAs in Virginia have obtained a federal exemption permit to treat opioid addiction with products containing buprenorphine. A PA in Virginia may prescribe controlled substances, as authorized by the practice agreement with a supervising physician. With appropriate training or experience, a PA in Virginia may receive a federal waiver to distribute products containing buprenorphine, as long as the supervising physician is certified, trained or licensed to treat and treat patients with an opioid use disorder. Will. Code 54.1-2952.1 The prescribing authority is site-specific.